Male baldness is physically benign though it is increasingly described as a “disease” based on claims that it is profoundly distressing. The medicalization of baldness was assessed using data extracted from a review of 37 male baldness psychosocial impact studies. Findings revealed most studies likely had commercial influences (78%), represented baldness as a disease (77%), were conducted on biased samples (68%), and advocated for baldness products/services (60%), omitting their limitations (68%). Health psychologists should challenge baldness medicalization so that men can make informed choices about what, if anything, they do with their baldness.
CITATION STYLE
Jankowski, G. S., & Frith, H. (2022). Psychology’s medicalization of male baldness. Journal of Health Psychology, 27(9), 2161–2180. https://doi.org/10.1177/13591053211024724
Mendeley helps you to discover research relevant for your work.